Richard Mularski to Risk Assessment
This is a "connection" page, showing publications Richard Mularski has written about Risk Assessment.
Connection Strength
0.334
-
Informing Patient-Centered Care Through Stakeholder Engagement and Highly Stratified Quantitative Benefit-Harm Assessments. Value Health. 2020 05; 23(5):616-624.
Score: 0.127
-
A benefit-harm analysis of adding basal insulin vs. sulfonylurea to metformin to manage type II diabetes mellitus in people with multiple chronic conditions. J Clin Epidemiol. 2019 09; 113:92-100.
Score: 0.119
-
Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessment. BMJ Open. 2019 08 30; 9(8):e028438.
Score: 0.030
-
A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J. 2015 Sep; 46(3):651-62.
Score: 0.022
-
Development, validation, and results of a risk-standardized measure of hospital 30-day mortality for patients with exacerbation of chronic obstructive pulmonary disease. J Hosp Med. 2013 Aug; 8(8):428-35.
Score: 0.020
-
Structured approaches to pain management in the ICU. Chest. 2009 Jun; 135(6):1665-1672.
Score: 0.015